Jason Pitofsky
At a glance: Jason Pitofsky is Svp Controller at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 6, 2026, reported a sale of $412K. On file: 0 purchase lines ($0) and 20 sale lines ($5.7M).
Disclosed holdings: about $4.0M of REGN stock: 4,272 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 6, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Svp Controller at Regeneron Pharmaceuticals, Inc. (REGN); Vp Controller at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Jason Pitofsky's InsiderPrint
20 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 20 times a year, typically $170K a trade; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (20)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Bruce N. JacobsCFO · KYMR · 99% match
- Christopher A. KroegerCEO · MPLT · 98% match
- Jeremy G. ChadwickCOO · KYMR · 98% match
- Markus GloecklerCTO · FSLR · 98% match
- William John SiboldCEO, President · MDGL · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 4397,716 held (−5%) | $939.57 | $412K | -0.7% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 5757,141 held (−7%) | $940.46 | $541K | -0.8% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 9826,159 held (−14%) | $941.58 | $925K | -1.0% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1,2154,944 held (−20%) | $942.31 | $1.1M | -1.0% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 5294,415 held (−11%) | $943.53 | $499K | -1.2% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 1084,307 held (−2%) | $944.22 | $102K | -1.2% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 354,272 held (−1%) | $945.61 | $33K | -1.4% |
| Nov 6SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 179 | $950.76 | $170K | -1.9% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 206,288 held (−0%) | $775.95 | $16K | +20.2% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5215,767 held (−8%) | $776.43 | $405K | +20.1% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 3915,376 held (−7%) | $777.51 | $304K | +19.9% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5634,813 held (−10%) | $778.35 | $438K | +19.8% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2054,608 held (−4%) | $779.56 | $160K | +19.6% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 754,533 held (−2%) | $780.06 | $59K | +19.5% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 264,507 held (−1%) | $781.37 | $20K | +19.3% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 374,470 held (−1%) | $782.67 | $29K | +19.1% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1444,326 held (−3%) | $783.23 | $113K | +19.1% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 14,325 held (−0%) | $784.66 | $785 | +18.8% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 534,272 held (−1%) | $785.72 | $42K | +18.7% |
| Nov 10SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell | 4314,233 held (−9%) | $651.43 | $281K | +43.2% |
- Sell
Svp Controller Jason Pitofsky sold $16K of REGN at $775.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp Controller Jason Pitofsky sold $405K of REGN at $776.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp Controller Jason Pitofsky sold $304K of REGN at $777.51 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp Controller Jason Pitofsky sold $438K of REGN at $778.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp Controller Jason Pitofsky sold $160K of REGN at $779.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp Controller Jason Pitofsky sold $59K of REGN at $780.06 — pre-scheduled 10b5-1 plan sale.
Follow Jason Pitofsky
Get one email when Jason Pitofsky files a new purchase or sale. Free.
At most one email a day about Jason Pitofsky, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.